3amrogram's profile picture. Postdoctoral Research Fellow, Department of Surgery @MayoClinic. Interested in Gen Surg, GI & HPB research. Previously applied ergonomics researcher.

Amro Abdelrahman, MBBS, MS

@3amrogram

Postdoctoral Research Fellow, Department of Surgery @MayoClinic. Interested in Gen Surg, GI & HPB research. Previously applied ergonomics researcher.

Fixado

Excited @NCCN highlighted our findings @JNCCN on the diagnostic accuracy of FDG-PET in predicting response & survival following NAT on BR/LA PDAC. Thanks to all coauthors & mentors: Drs. Truty & Goenka @MayoClinicSurg @MayoRadiology @MayoRadOnc @MayoCancerCare @MayoClinic

A new @JNCCN study suggests a method to predict outcomes with high accuracy prior to surgery for pancreatic cancer patients. Learn more: nccn.org/home/news/news… @MayoCancerCare #pancsm

NCCN's tweet image. A new @JNCCN study suggests a method to predict outcomes with high accuracy prior to surgery for pancreatic cancer patients. 
Learn more: nccn.org/home/news/news…
@MayoCancerCare #pancsm


Amro Abdelrahman, MBBS, MS repostou

Our exceptional staff make Category-of-One care possible as they extend hope and healing to our patients and their families each day. This fall, we’re honoring our staff’s collective achievements across our campuses, celebrating at Mayo Clinic in Rochester today.

GFarrugiaMD's tweet image. Our exceptional staff make Category-of-One care possible as they extend hope and healing to our patients and their families each day. This fall, we’re honoring our staff’s collective achievements across our campuses, celebrating at Mayo Clinic in Rochester today.
GFarrugiaMD's tweet image. Our exceptional staff make Category-of-One care possible as they extend hope and healing to our patients and their families each day. This fall, we’re honoring our staff’s collective achievements across our campuses, celebrating at Mayo Clinic in Rochester today.
GFarrugiaMD's tweet image. Our exceptional staff make Category-of-One care possible as they extend hope and healing to our patients and their families each day. This fall, we’re honoring our staff’s collective achievements across our campuses, celebrating at Mayo Clinic in Rochester today.
GFarrugiaMD's tweet image. Our exceptional staff make Category-of-One care possible as they extend hope and healing to our patients and their families each day. This fall, we’re honoring our staff’s collective achievements across our campuses, celebrating at Mayo Clinic in Rochester today.

Amro Abdelrahman, MBBS, MS repostou

We are proud that Mayo Clinic has been recognized once again as a leader in healthcare, a reflection of the unwavering commitment of our staff and their dedication to excellence, innovation, and putting patients first. health.usnews.com/best-hospitals

GFarrugiaMD's tweet image. We are proud that Mayo Clinic has been recognized once again as a leader in healthcare, a reflection of the unwavering commitment of our staff and their dedication to excellence, innovation, and putting patients first. health.usnews.com/best-hospitals

Amro Abdelrahman, MBBS, MS repostou

#GUTImage from the paper by Ekstrom et al entitled "Glucocorticoid receptor suppresses GATA6-mediated RNA polymerase II pause release to modulate classical subtype identity in pancreatic cancer" via bit.ly/3SHMGkH @3amrogram @ProfJohnsen #PancreaticCancer

Gut_BMJ's tweet image. #GUTImage from the paper by Ekstrom et al entitled

"Glucocorticoid receptor suppresses GATA6-mediated RNA polymerase II pause release to modulate classical subtype identity in pancreatic cancer" via

bit.ly/3SHMGkH

@3amrogram @ProfJohnsen #PancreaticCancer

Amro Abdelrahman, MBBS, MS repostou

A study co-authored by @MayoClinic surgeons looked at the role of KRAS mutations in the prognosis of pancreatic ductal adenocarcinoma (PDAC). Identifying these mutations early can inform treatment plans to improve patient outcomes. #PancreaticCancer mayocl.in/4kZmcHo

MayoClinicSurg's tweet image. A study co-authored by @MayoClinic surgeons looked at the role of KRAS mutations in the prognosis of pancreatic ductal adenocarcinoma (PDAC). Identifying these mutations early can inform treatment plans to improve patient outcomes. #PancreaticCancer mayocl.in/4kZmcHo

Amro Abdelrahman, MBBS, MS repostou

#GUTImage from the paper by Ekstrom et al entitled "Glucocorticoid receptor suppresses GATA6-mediated RNA polymerase II pause release to modulate classical subtype identity in pancreatic cancer" via bit.ly/3SHMGkH @3amrogram @ProfJohnsen #PancreaticCancer

Gut_BMJ's tweet image. #GUTImage from the paper by Ekstrom et al entitled

"Glucocorticoid receptor suppresses GATA6-mediated RNA polymerase II pause release to modulate classical subtype identity in pancreatic cancer" via

bit.ly/3SHMGkH

@3amrogram @ProfJohnsen #PancreaticCancer

Amro Abdelrahman, MBBS, MS repostou

Featured: Molecular KRAS ctDNA Predicts Metastases and Survival in #PancreaticCancer : A Prospective Cohort Study. @RAR__MD @3amrogram @TELL_Starlinger ow.ly/oPY750VZArg @GilbertZMurimwa @SyedAAhmad5

AnnSurgOncol's tweet image. Featured: Molecular KRAS ctDNA Predicts Metastases and Survival in #PancreaticCancer : A Prospective Cohort Study.  @RAR__MD @3amrogram @TELL_Starlinger

ow.ly/oPY750VZArg 

@GilbertZMurimwa
@SyedAAhmad5

Amro Abdelrahman, MBBS, MS repostou

🚀 Dreaming of a research career? Learn how to secure your position! 🌍 ✅ Explore opportunities ✅ Build a strong application ✅ Nail the interview 📅 Friday, June 27, 2025 | 11 AM – 2 PM CT (16:00 – 19:00 GMT). Limited SEATS! Register Now: forms.gle/n5v2uypivoJcpT…


Amro Abdelrahman, MBBS, MS repostou

Super happy to see this commentary in ⁦@Gut_BMJ⁩ about our recent work!!! Truly one of the most exciting and rewarding projects of my career. So happy to have worked with Tom Ekstrom on this exciting project! #FuturePI #ProudMentor #BoschStiftung gut.bmj.com/content/early/…


Amro Abdelrahman, MBBS, MS repostou

A new study led by @MayoClinic surgeons Dr. Mark Truty & Dr. Jennifer Leiting links a specific genetic mutation to a higher risk of cancer spread in patients diagnosed with #PancreaticCancer. mayocl.in/4iF3uUu @AnnSurgOncol

MayoClinicSurg's tweet image. A new study led by @MayoClinic surgeons Dr. Mark Truty & Dr. Jennifer Leiting links a specific genetic mutation to a higher risk of cancer spread in patients diagnosed with #PancreaticCancer. mayocl.in/4iF3uUu  @AnnSurgOncol

Amro Abdelrahman, MBBS, MS repostou

For the seventh consecutive year, Mayo Clinic is ranked No. 1 on @Newsweek’s World’s Best Hospitals 2025 list. mayocl.in/4hU17Ny

GFarrugiaMD's tweet image. For the seventh consecutive year, Mayo Clinic is ranked No. 1 on @Newsweek’s World’s Best Hospitals 2025 list. mayocl.in/4hU17Ny

Amro Abdelrahman, MBBS, MS repostou

For the 7th straight year, Newsweek has named Mayo Clinic the No. 1 hospital in its "World’s Best Hospitals" rankings. “Mayo Clinic’s dedicated staff make this possible,” says CEO @GFarrugiaMDGianrico Read more: mayocl.in/41ko7OH

MayoClinic's tweet image. For the 7th straight year, Newsweek has named Mayo Clinic the No. 1 hospital in its "World’s Best Hospitals" rankings.  

“Mayo Clinic’s dedicated staff make this possible,” says CEO @GFarrugiaMDGianrico Read more: mayocl.in/41ko7OH

Amro Abdelrahman, MBBS, MS repostou

#GUTOnline paper by Ekstrom et al on "Glucocorticoid receptor suppresses GATA6-mediated RNA polymerase II pause release to modulate classical subtype identity in pancreatic cancer" via bit.ly/3Q1wUzF @3amrogram @ProfJohnsen #PancreaticCancer

Gut_BMJ's tweet image. #GUTOnline paper by Ekstrom et al on 

"Glucocorticoid receptor suppresses GATA6-mediated RNA polymerase II pause release to modulate classical subtype identity in pancreatic cancer" via

bit.ly/3Q1wUzF

@3amrogram @ProfJohnsen #PancreaticCancer
Gut_BMJ's tweet image. #GUTOnline paper by Ekstrom et al on 

"Glucocorticoid receptor suppresses GATA6-mediated RNA polymerase II pause release to modulate classical subtype identity in pancreatic cancer" via

bit.ly/3Q1wUzF

@3amrogram @ProfJohnsen #PancreaticCancer
Gut_BMJ's tweet image. #GUTOnline paper by Ekstrom et al on 

"Glucocorticoid receptor suppresses GATA6-mediated RNA polymerase II pause release to modulate classical subtype identity in pancreatic cancer" via

bit.ly/3Q1wUzF

@3amrogram @ProfJohnsen #PancreaticCancer
Gut_BMJ's tweet image. #GUTOnline paper by Ekstrom et al on 

"Glucocorticoid receptor suppresses GATA6-mediated RNA polymerase II pause release to modulate classical subtype identity in pancreatic cancer" via

bit.ly/3Q1wUzF

@3amrogram @ProfJohnsen #PancreaticCancer

Amro Abdelrahman, MBBS, MS repostou

#GUTOnline paper by Ekstrom et al on "Glucocorticoid receptor suppresses GATA6-mediated RNA polymerase II pause release to modulate classical subtype identity in pancreatic cancer" via bit.ly/3Q1wUzF @3amrogram @ProfJohnsen #PancreaticCancer

Gut_BMJ's tweet image. #GUTOnline paper by Ekstrom et al on 

"Glucocorticoid receptor suppresses GATA6-mediated RNA polymerase II pause release to modulate classical subtype identity in pancreatic cancer" via

bit.ly/3Q1wUzF

@3amrogram @ProfJohnsen #PancreaticCancer
Gut_BMJ's tweet image. #GUTOnline paper by Ekstrom et al on 

"Glucocorticoid receptor suppresses GATA6-mediated RNA polymerase II pause release to modulate classical subtype identity in pancreatic cancer" via

bit.ly/3Q1wUzF

@3amrogram @ProfJohnsen #PancreaticCancer
Gut_BMJ's tweet image. #GUTOnline paper by Ekstrom et al on 

"Glucocorticoid receptor suppresses GATA6-mediated RNA polymerase II pause release to modulate classical subtype identity in pancreatic cancer" via

bit.ly/3Q1wUzF

@3amrogram @ProfJohnsen #PancreaticCancer
Gut_BMJ's tweet image. #GUTOnline paper by Ekstrom et al on 

"Glucocorticoid receptor suppresses GATA6-mediated RNA polymerase II pause release to modulate classical subtype identity in pancreatic cancer" via

bit.ly/3Q1wUzF

@3amrogram @ProfJohnsen #PancreaticCancer

Amro Abdelrahman, MBBS, MS repostou

#GUTOnline paper by Ekstrom et al on "Glucocorticoid receptor suppresses GATA6-mediated RNA polymerase II pause release to modulate classical subtype identity in pancreatic cancer" via bit.ly/3Q1wUzF @3amrogram @ProfJohnsen #PancreaticCancer

Gut_BMJ's tweet image. #GUTOnline paper by Ekstrom et al on 

"Glucocorticoid receptor suppresses GATA6-mediated RNA polymerase II pause release to modulate classical subtype identity in pancreatic cancer" via

bit.ly/3Q1wUzF

@3amrogram @ProfJohnsen #PancreaticCancer
Gut_BMJ's tweet image. #GUTOnline paper by Ekstrom et al on 

"Glucocorticoid receptor suppresses GATA6-mediated RNA polymerase II pause release to modulate classical subtype identity in pancreatic cancer" via

bit.ly/3Q1wUzF

@3amrogram @ProfJohnsen #PancreaticCancer
Gut_BMJ's tweet image. #GUTOnline paper by Ekstrom et al on 

"Glucocorticoid receptor suppresses GATA6-mediated RNA polymerase II pause release to modulate classical subtype identity in pancreatic cancer" via

bit.ly/3Q1wUzF

@3amrogram @ProfJohnsen #PancreaticCancer
Gut_BMJ's tweet image. #GUTOnline paper by Ekstrom et al on 

"Glucocorticoid receptor suppresses GATA6-mediated RNA polymerase II pause release to modulate classical subtype identity in pancreatic cancer" via

bit.ly/3Q1wUzF

@3amrogram @ProfJohnsen #PancreaticCancer

Amro Abdelrahman, MBBS, MS repostou

Mayo Clinic hospitals in Arizona, Florida, and Minnesota have once again been recognized by @Healthgrades as part of their 2025 America's 50 Best Hospitals list. Learn more: mayocl.in/40CUGak

GFarrugiaMD's tweet image. Mayo Clinic hospitals in Arizona, Florida, and Minnesota have once again been recognized by @Healthgrades as part of their 2025 America's 50 Best Hospitals list. Learn more: mayocl.in/40CUGak

Huge congrats to @ProfJohnsen & Tom on this impactful paper @Gut_BMJ! 🎉 I am so happy for the opportunity to help & I look forward to seeing the impact this work and continuing this productive collaboration to improve the pancreatic cancer outcomes #PDAC 🌟

A new @JNCCN study suggests a method to predict outcomes with high accuracy prior to surgery for pancreatic cancer patients. Learn more: nccn.org/home/news/news… @MayoCancerCare #pancsm

NCCN's tweet image. A new @JNCCN study suggests a method to predict outcomes with high accuracy prior to surgery for pancreatic cancer patients. 
Learn more: nccn.org/home/news/news…
@MayoCancerCare #pancsm


Amro Abdelrahman, MBBS, MS repostou

Progress in metastatic #GastricCancer treatment show the benefits of combining targeted therapies with surgery. Dr. Travis Grotz, @MayoClinic #SurgicalOncologist, says an individualized approach can help ensure optimal patient outcomes. Learn more: bit.ly/40z7GgS

MayoClinicSurg's tweet image. Progress in metastatic #GastricCancer treatment show the benefits of combining targeted therapies with surgery. Dr. Travis Grotz, @MayoClinic #SurgicalOncologist, says an individualized approach can help ensure optimal patient outcomes. Learn more: bit.ly/40z7GgS

So delighted to welcome Dr. @LakshikaTennak3 to our statistical team @JSurgRes 🎉 We're so fortunate to have your expertise! #SurgicalResearch #Statistics #NewTeamMember #JSR

🔥 Please welcome Lakshika Tennakoon, MD,MPhil, has been selected to serve as Associate Statistics Editor; she will be joining our current Statistics Editor, Mazen Zenati, MD, MPH, PhD, and Associate Statistics Editors, Kanhua Yin, MD, MPH, and Amro Abdelrahman, MBBS, MS.

JSurgRes's tweet image. 🔥 Please welcome 
Lakshika Tennakoon, MD,MPhil, has been selected to serve as Associate Statistics Editor; she will be joining our current Statistics Editor, Mazen Zenati, MD, MPH, PhD, and Associate Statistics Editors, Kanhua Yin, MD, MPH, and Amro Abdelrahman, MBBS, MS.
JSurgRes's tweet image. 🔥 Please welcome 
Lakshika Tennakoon, MD,MPhil, has been selected to serve as Associate Statistics Editor; she will be joining our current Statistics Editor, Mazen Zenati, MD, MPH, PhD, and Associate Statistics Editors, Kanhua Yin, MD, MPH, and Amro Abdelrahman, MBBS, MS.


Amro Abdelrahman, MBBS, MS repostou

Welcome !! Excellent editions in the journal . Thank you @scottlemaire for your leadership in taking the journal to new heights !! Up and onwards 🚀

🔥 Please welcome Lakshika Tennakoon, MD,MPhil, has been selected to serve as Associate Statistics Editor; she will be joining our current Statistics Editor, Mazen Zenati, MD, MPH, PhD, and Associate Statistics Editors, Kanhua Yin, MD, MPH, and Amro Abdelrahman, MBBS, MS.

JSurgRes's tweet image. 🔥 Please welcome 
Lakshika Tennakoon, MD,MPhil, has been selected to serve as Associate Statistics Editor; she will be joining our current Statistics Editor, Mazen Zenati, MD, MPH, PhD, and Associate Statistics Editors, Kanhua Yin, MD, MPH, and Amro Abdelrahman, MBBS, MS.
JSurgRes's tweet image. 🔥 Please welcome 
Lakshika Tennakoon, MD,MPhil, has been selected to serve as Associate Statistics Editor; she will be joining our current Statistics Editor, Mazen Zenati, MD, MPH, PhD, and Associate Statistics Editors, Kanhua Yin, MD, MPH, and Amro Abdelrahman, MBBS, MS.


Amro Abdelrahman, MBBS, MS repostou

Featured: Outcomes of #NeoadjuvantChemotherapy for Invasive Intraductal Papillary #MucinousNeoplasm Compared with de Novo #PancreaticAdenocarcinoma . @3amrogram @ThielsCA @Seanpcleary ow.ly/IL5g50Ui7Xa @jhatjhmi1 @SyedAAhmad5

AnnSurgOncol's tweet image. Featured: Outcomes of #NeoadjuvantChemotherapy for Invasive Intraductal Papillary #MucinousNeoplasm Compared with de Novo #PancreaticAdenocarcinoma .  @3amrogram @ThielsCA @Seanpcleary

ow.ly/IL5g50Ui7Xa 

@jhatjhmi1
@SyedAAhmad5

Loading...

Something went wrong.


Something went wrong.